Ocugen (OCGN) Free Cash Flow (2014 - 2026)
Ocugen's (OCGN) quarterly Free Cash Flow came in at -$21.8 million in Q1 2026, down 12.53% YoY from -$24.9 million in Q1 2025, and down 54.31% on a QoQ basis from -$14.1 million in Q4 2025.
Ocugen (OCGN) Free Cash Flow (2014 - 2026) Analysis & Trends
Ocugen (OCGN) has 13 years of Free Cash Flow data on file, last reported at -$21.8 million in Q1 2026.
- Quarterly Free Cash Flow fell 12.53% year-over-year to -$21.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$59.6 million (down 14.67% YoY) and the FY2025 annual result came in at -$57.1 million, down 25.53% from the prior year.
- Free Cash Flow slipped to -$21.8 million in Q1 2026, from -$14.1 million in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of -$5.7 million in Q4 2023 to a low of -$21.8 million in Q1 2026.
- A 5-year average of -$14.7 million and a median of -$14.4 million in 2024 frame the typical range for Free Cash Flow.
- Annual changes were most pronounced in 2022 — Free Cash Flow sank 175.78% — and 2023, when it soared 65.43%.
- Tracing OCGN's Free Cash Flow over 5 years: stood at -$16.6 million in 2022, then soared by 65.43% to -$5.7 million in 2023, then tumbled by 80.88% to -$10.4 million in 2024, then sank by 36.14% to -$14.1 million in 2025, then sank by 54.31% to -$21.8 million in 2026.
- The last three Free Cash Flow figures came in at -$21.8 million (Q1 2026), -$14.1 million (Q4 2025), and -$12.9 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.01 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 572.80 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -389.61 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 437.80 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -2.33 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 477.44 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 292.04 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -95.09 Mn |
| 10 | Ocugen | 457.71 Mn | 357.61 Mn | - | -12.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -12.22 Mn |
| Jun 30, 2026 | -12.22 Mn |
| Mar 31, 2026 | -21.80 Mn |
| Mar 31, 2026 | -21.80 Mn |
| Dec 31, 2025 | -14.13 Mn |
| Dec 31, 2025 | -14.13 Mn |
| Sep 30, 2025 | -12.88 Mn |
| Sep 30, 2025 | -12.88 Mn |
| Jun 30, 2025 | -10.77 Mn |
| Jun 30, 2025 | -10.77 Mn |
| Mar 31, 2025 | -19.37 Mn |
| Mar 31, 2025 | -19.37 Mn |
| Dec 31, 2024 | -10.38 Mn |
| Dec 31, 2024 | -10.38 Mn |
| Sep 30, 2024 | -14.40 Mn |
| Sep 30, 2024 | -14.40 Mn |
| Jun 30, 2024 | -7.81 Mn |
| Jun 30, 2024 | -7.81 Mn |
| Mar 31, 2024 | -12.95 Mn |
| Mar 31, 2024 | -12.95 Mn |